Novozymes opens international sales office

Bagsvœrd/Denmark – Novozymes Biopharma UK, a wholly owned subsidiary of Novozymes, has opened a sales office in Cambridge, Massachusetts. The new office will provide a rapid and effective service to a global customer base requiring high quality recombinant ingredients for biopharmaceutical production. Novozymes’ biopharmaceutical ingredients range has been developed exclusively for industrial cell culture and protein drug formulation. The entire range is animal free, manufactured to GMP and backed by a comprehensive risk management strategy providing customers with a secure supply of compliant and consistent critical raw materials.